Meloxicam

美洛昔康

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameMeloxicam
Drug Alias Namemeloxicamum美络昔康美洛西康meloxicamUticox +[25] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsCyclooxygenase-1 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsContraceptionLow Back PainPain +[18] 
Global Approved IndicationsOsteoarthritisArthritis, RheumatoidArthritis, Juvenile +[4] 
Approved Indications in ChinaArthritis, RheumatoidSpondylitis, Ankylosing
Original Approved Country/TerritoryGermany
Original Approved Date1995/01/01
Country/TerritoryBelgiumCanadaUnited States +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesBidachem SpaC.H. Boehringer Sohn Ag & Co. KgCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd +[7] 
Inactive CompaniesUniversity of StellenboschBaudax Bio IncRothman Orthopaedic Institute +[15] 
Active IndicationsPainPain, PostoperativeOsteoarthritis +[6] 
Inactive IndicationsContraceptionLow Back PainPostoperative Complications +[12] 

Other Information

ATC CodeM01AC06
Related LinksWikipediaDrugBankKEGG